Tatiana Pedrosa

University of São Paulo (USP) - Rheumatology Division

Brazil

SCHOLARLY PAPERS

2

DOWNLOADS

194

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (2)

1.

Safety and Immunogenicity of CoronaVac in People Living with HIV

Number of pages: 21 Posted: 22 Sep 2021
University of São Paulo (USP) - Department of Infectious and Parasitic Diseases, University of São Paulo (USP) - Department of Infectious and Parasitic Diseases, University of São Paulo (USP) - Department of Infectious and Parasitic Diseases, University of São Paulo (USP) - Department of Infectious and Parasitic Diseases, University of São Paulo (USP) - Department of Infectious and Parasitic Diseases, University of São Paulo (USP) - Department of Infectious and Parasitic Diseases, University of São Paulo (USP) - Department of Infectious and Parasitic Diseases, University of São Paulo (USP) - Rheumatology DivisionUniversity of São Paulo (USP) - Rheumatology Division, University of São Paulo (USP) - Rheumatology Division, University of São Paulo (USP) - Rheumatology Division, University of São Paulo (USP) - Rheumatology Division, University of São Paulo (USP) - Rheumatology Division, University of São Paulo (USP) - Rheumatology Division, University of São Paulo (USP) - Department of Infectious and Parasitic Diseases, University of São Paulo (USP) - Department of Pathology, University of São Paulo (USP) - Rheumatology Division, University of São Paulo (USP) - Hospital das Clinicas HCFMUSP and University of São Paulo (USP) - Department of Infectious and Parasitic Diseases
Downloads 120 (423,105)

Abstract:

Loading...

SARS-CoV-2, COVID-19, vaccine, HIV, immunogenicity, neutralizing antibodies, CoronaVac

2.

Dynamics of Inactivated SARS-CoV-2 Vaccine Antibody Response in SARS-CoV-2-Seropositive Autoimmune Rheumatic Disease Patients

Number of pages: 31 Posted: 29 Jul 2021
University of São Paulo (USP) - Rheumatology DivisionUniversity of São Paulo (USP) - Rheumatology Division, University of São Paulo (USP) - Rheumatology Division, University of São Paulo (USP) - Rheumatology Division, University of São Paulo (USP) - Rheumatology Division, University of São Paulo (USP) - Rheumatology Division, University of São Paulo (USP) - Rheumatology Division, University of São Paulo (USP) - Rheumatology Division, University of São Paulo (USP) - Rheumatology Division, University of São Paulo (USP) - Faculty of Medicine, University of São Paulo (USP) - Rheumatology Division, University of São Paulo (USP) - Rheumatology Division, University of São Paulo (USP) - Rheumatology Division, University of São Paulo (USP) - Rheumatology Division, University of São Paulo (USP) - Rheumatology Division, University of São Paulo (USP) - Rheumatology Division, University of São Paulo (USP) - Rheumatology Division, University of São Paulo (USP) - Divisão do Laboratório Central, University of São Paulo (USP) - Rheumatology Division, University of São Paulo (USP) - LIM-46 e LIM-49 do Instituto de Medicina Tropical, University of São Paulo (USP) - Rheumatology Division, University of São Paulo (USP) - Hospital das Clinicas HCFMUSP, University of São Paulo (USP) - Rheumatology Division and University of São Paulo (USP) - Rheumatology Division
Downloads 74 (580,905)

Abstract:

Loading...

autoimmune rheumatic diseases, COVID-19, vaccine, seropositive, immunogenicity